Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
NovAb logo — Pioneering the future of medicinal science with groundbreaki...

NovAb

Pioneering the future of medicinal science with groundbreaking therapeutic drugs and precision diagnostic solutions

Founded 2013 Biotechnology, Health and Wellness +1

General Information

Company Name NovAb
Founded Year 2013
Founders / Decision Makers
Team member
Industries Biotechnology, Health and Wellness, Life Sciences
Social

Get notified when NovAb moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NovAb

NovAb is a pioneering biotechnology company founded in 2013. The company's slogan, "Pioneering the future of medicinal science with groundbreaking therapeutic drugs and precision diagnostic solutions," encapsulates its dedication to advancing the field of medicinal science. NovAb specializes in developing therapeutic drugs, diagnostic reagents, and biomedical research reagents within the Biotechnology, Health and Wellness, and Life Sciences industries. The company's unique platform leverages Variable Lymphocyte Receptors (VLR) to create targeted therapies. Notably, NovAb focuses on producing monoclonal VLR antibodies for specific targets, including a plasma cell-specific surface target crucial for treating multiple myeloma, autoimmune diseases, and transplant rejection. Additionally, NovAb is driving innovation in high-sensitivity polymeric antibody diagnostic reagents for infectious agent detection, as well as developing advanced research reagents to identify and differentiate closely related glycan structures. With its innovative approach and impactful solutions, NovAb presents promising opportunities for investors seeking to support groundbreaking advancements in biotechnology and medical science.

Taxonomy: therapeutic drugs, diagnostic reagents, biomedical research, Variable Lymphocyte Receptors, monoclonal antibodies, multiple myeloma, autoimmune diseases, transplant rejection, polymeric antibody, infectious agent detection, glycan structures, precision medicine

No funding data available for NovAb yet.

Get notified when NovAb raises funding

NovAb Alternatives & Competitors

NovAb vs
Caprico Biotechnologies
Caprico Biotechnologies

Empowering breakthroughs in research and diagnostics through advanced flow cytometry reagents and se...

Seed
11-50 employees
Biotechnology, Health Care
NovAb vs
Australian Biosearch
Australian Biosearch

Your Life Science Specialists

4 employees
Biotechnology, IT
NovAb vs
Theoria Science
Theoria Science

Specializing in exosome research, pioneering cancer diagnostics and treatments, and excelling in ins...

Series Unknown
Biotechnology, Care Economy

FAQ About NovAb

Pioneering the future of medicinal science with groundbreaking therapeutic drugs and precision diagnostic solutions
NovAb was founded in 2013.
NovAb operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
Top alternatives and competitors to NovAb include Caprico Biotechnologies, Australian Biosearch, Theoria Science, Huibang Biological, Immuno Diagnostic Oy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NovAb and Caprico Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NovAb and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy